|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
Virtual Event
-
Virtual Event
The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice. The webinar will feature three expert speakers covering: - The evolving AML treatment landscape by professor Gail Roboz (New York) - Early Nordic experience with new […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
|
0 events,
|
1 event,
-
Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics via this Zoom-link. If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden. |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: Assess the current minimal residual disease testing modalities/methods Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|